Single-Clone MCB Production for Robust H-1 Parvovirus Output
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing H-1 parvovirus production methods using NB-324K mixed cells are limited by mechanical instability, lower transfection efficiency, and sensitivity to ammonia, leading to suboptimal productivity and reproducibility.
Innovation Solution
Development of a single clone Master Cell Bank (MCB) process involving selective cloning, propagation, and infection with sequenced plasmid DNA to enhance cell stability, transfection efficiency, and robustness, followed by optimized virus production and purification steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If NB-324K mixed cells are used for H-1PV production, then production can be carried out using established methods, but mechanical stability is poor and transfection efficiency is low
Solution Approach 1:
The patent segments the cell population from a mixed clone (NB-324K) into multiple single clones through serial dilution and single-cell isolation. This segmentation allows selection of clones with superior mechanical stability and transfection efficiency while maintaining the established production framework.
Solution Approach 2:
The patent changes the cellular parameter from mixed population to single clone by modifying the isolation and selection process. This parameter change results in cells with enhanced mechanical stability and improved transfection efficiency while preserving the overall production methodology.
2Productivity
If NB-324K mixed cells are used for H-1PV production, then routine production can be maintained, but transfection efficiency is low leading to suboptimal productivity
Solution Approach 1:
The patent performs preliminary action by isolating and characterizing single clones before scaling up production. This preliminary selection of high-performance clones ensures superior transfection efficiency and productivity are achieved before committing to large-scale manufacturing.
Solution Approach 2:
The patent changes the cellular parameter from mixed population to selected single clone, which fundamentally improves transfection efficiency. This parameter change directly enhances productivity by enabling more effective gene delivery and viral production.
3Reliability
If NB-324K mixed cells are used for H-1PV production, then current production protocols can be used, but cells show sensitivity to ammonia reducing robustness
Solution Approach 1:
The patent segments the cell population to identify and isolate single clones with superior ammonia resistance. This segmentation enables selection of robust clones that can withstand ammonia exposure better than the mixed population, improving overall process reliability.
Solution Approach 2:
The patent changes the cellular parameter from mixed clone to selected single clone, which alters the physiological response to ammonia. The selected clones exhibit enhanced robustness and reduced sensitivity to ammonia, improving reliability under stress conditions.
4Reliability
If single clone MCB is developed through extensive cloning and selection, then mechanical stability and transfection efficiency improve, but process complexity increases
Solution Approach 1:
The patent applies segmentation through systematic single-cell isolation and clone selection. While this increases initial process complexity, it creates a foundation for more reliable and efficient production that simplifies downstream operations and ensures consistent performance.
Solution Approach 2:
The patent changes the cellular parameter from mixed to single clone, which initially increases process complexity but ultimately improves reliability. The selected clones exhibit superior mechanical stability and transfection efficiency, reducing variability and simplifying process control in later stages.
Data Source
AI summary
The present invention provides a robust single clone Master Cell Bank (MCB) for an optimized production of H-1 parvovirus (H-1 PV) which is suitable to increase infectious parvovirus production compared to standard producer NB-324K mixed cells.